11/14/2024
8:00 PM | Krystal Biotech (Subject)
Redmile Group, LLC (Filed by)
| Form SC 13G/A | |
11/04/2024
7:04 AM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
7:05 AM | Krystal Biotech (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/16/2024
11:28 AM | Krystal Biotech (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G | |
09/13/2024
4:41 PM | Krystal Biotech (Issuer)
ROSSI DINO A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:44 PM | Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:45 PM | Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
09/12/2024
3:33 PM | Krishnan Krish S (Reporting)
Krystal Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
3:33 PM | Krishnan Suma (Reporting)
Krystal Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024
3:31 PM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/05/2024
7:03 AM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/05/2024
7:08 AM | Krystal Biotech (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/10/2024
12:14 PM | Krystal Biotech (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
07/08/2024
3:32 PM | BlackRock Inc. (Filed by)
Krystal Biotech (Subject)
| Form SC 13G/A | |
07/01/2024
6:32 PM | Krystal Biotech (Issuer)
Mason Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
6:34 PM | JANNEY DANIEL (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
6:37 PM | Gangolli Julian S (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
6:21 PM | Krystal Biotech (Issuer)
ROSSI DINO A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
6:24 PM | Krystal Biotech (Issuer)
Sutherland Everett Rand (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
6:29 PM | Krystal Biotech (Issuer)
Mazzacco Catherine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
7:31 PM | Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
7:33 PM | Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
5:17 PM | Gangolli Julian S (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
3:38 PM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2024
3:51 PM | Gangolli Julian S (Reporting)
Krystal Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/06/2024
7:04 AM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2024
7:17 AM | Krystal Biotech (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/04/2024
3:08 PM | Krystal Biotech (Filer)
| Form DEF 14A | |
04/04/2024
3:09 PM | Krystal Biotech (Filer)
| Form DEFA14A | |
03/11/2024
7:24 PM | Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:27 PM | Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
3:36 PM | Krishnan Krish S (Reporting)
Krystal Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
3:37 PM | Krishnan Suma (Reporting)
Krystal Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
7:20 PM | Krystal Biotech (Issuer)
ROMANO KATHRYN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
7:09 PM | Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
7:13 PM | Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
7:16 PM | Krystal Biotech (Issuer)
ROMANO KATHRYN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
8:39 PM | Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
8:33 PM | Krystal Biotech (Issuer)
ROMANO KATHRYN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
8:36 PM | Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
12:35 PM | Krystal Biotech (Subject)
ROMANO KATHRYN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
This Bull Market Indicator called NVDA at $116 (Ad) Every now and again we find an investment idea so incredible we can’t help but share.
And today is one of those rare days…
Except, today we won't be giving you insight on any one particular stock…
But rather, insight on a revolutionary new stock picking indicator…
In fact, within the last year, this indicator has become famous for a multitude of reasons…
But one of the biggest was because of the buy signal it issued on October 18th, 2022.
In fact, on that very day, it said to buy NVDA at $116.37…
Anyone who did would be sitting on a tremendously large return today…
But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run… All you have to do is follow this link here |
02/26/2024
6:59 AM | Krystal Biotech (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/26/2024
7:04 AM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2024
6:49 AM | Krystal Biotech (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
8:25 AM | Avoro Capital Advisors LLC (Filed by)
Krystal Biotech (Subject)
| Form SC 13G/A | |
01/29/2024
2:26 PM | Krystal Biotech (Subject)
| Form SC 13G/A | |
01/24/2024
4:44 PM | Krystal Biotech (Issuer)
Romano Kathryn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
10:43 AM | Krystal Biotech (Subject)
Romano Kathryn (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023
4:17 PM | Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
4:23 PM | Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
3:19 PM | Krishnan Krish S (Reporting)
Krystal Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2023
3:20 PM | Krishnan Suma (Reporting)
Krystal Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
